Stryker To Pay $1.4M Over Bone Protein Marketing
By Nick Brown ( August 26, 2010, 12:27 PM EDT) -- Stryker Biotech LLC has agreed to pay $1.35 million to Massachusetts to settle claims that the company marketed its OP-1 bone protein for uses not approved by the U.S. Food and Drug Administration....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.